Correlation Between Mereo BioPharma and Aeorema Communications

Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Aeorema Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Aeorema Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mereo BioPharma Group and Aeorema Communications Plc, you can compare the effects of market volatilities on Mereo BioPharma and Aeorema Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Aeorema Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Aeorema Communications.

Diversification Opportunities for Mereo BioPharma and Aeorema Communications

0.53

Correlation Coefficient

Mereo BioPharma  Aeorema Communications

Very weak diversification

The 3 months correlation between Mereo and Aeorema is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Aeorema Communications Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aeorema Communications and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Aeorema Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aeorema Communications has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Aeorema Communications go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Aeorema Communications

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to under-perform the Aeorema Communications. In addition to that, Mereo BioPharma is 2.5 times more volatile than Aeorema Communications Plc. It trades about -0.15 of its total potential returns per unit of risk. Aeorema Communications Plc is currently generating about -0.29 per unit of volatility. If you would invest  5,700  in Aeorema Communications Plc on December 24, 2024 and sell it today you would lose (1,350) from holding Aeorema Communications Plc or give up 23.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Mereo BioPharma Group  vs.  Aeorema Communications Plc

Mereo BioPharma Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Aeorema Communications

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aeorema Communications Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Mereo BioPharma and Aeorema Communications

The main advantage of trading using opposite Mereo BioPharma and Aeorema Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Aeorema Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aeorema Communications will offset losses from the drop in Aeorema Communications' long position.

The idea behind Mereo BioPharma Group and Aeorema Communications Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.